PNC Financial Services Group’s Spruce Biosciences SPRB Stock Holding History

PNC Financial Services Group’s Portfolio SPRB Stock Details SPRB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$17.2K	Buy	+355	New	+$18K	﹤0.01%	3936

Other funds holding SPRB

ACM

AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $8.36B AUM 14.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Pinnacle Wealth Planning Services Mansfield, Ohio $1.03B AUM 22.32% 1-Year Est. Return

PNC Financial Services Group's SPRB Position: Q3 2026 in Review

PNC Financial Services Group opened a new position in Spruce Biosciences (SPRB) in Q3 2026: 355 shares worth $17.2K. The stake represents ﹤0.01% of the portfolio and ranks #3936 among its holdings.

19 funds tracked by Wall St. Rank hold SPRB as of Q3 2026.

PNC Financial Services Group held 355 shares of Spruce Biosciences worth $17.2K as of Q3 2026.
Spruce Biosciences was a new PNC Financial Services Group position in Q3 2026.
Spruce Biosciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #3936 holding.
19 funds tracked by Wall St. Rank held Spruce Biosciences as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.